• Investing Ideas
  • /
  • South Korean Pharmaceuticals & Biotech They Run The Computer
251 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A217330

Cytogen
₩8,450.003.9%-51.7%₩189.0bn/aPS57.8xn/an/a

A138610

NIBEC
₩18,130.000%19.7%₩186.7bn/aPS10.6xn/an/a

A006620

DongKoo Bio & Pharma
₩6,810.00-2.2%19.9%₩185.9bn/aPE13xn/a1.8%

A060590

CTCBIO
₩7,770.000.3%-18.7%₩185.8bn/aPS1.4xn/an/a

A234080

JW Lifescience
₩11,870.00-0.6%-10.8%₩184.0bn/aPE7.2xn/a4.2%

A011040

Kyung Dong Pharmaceutical
₩6,770.001.7%-4.4%₩182.8bn/aPS1.1xn/a5.9%

A293780

AptaBio Therapeutics
₩7,980.0021.8%-12.6%₩177.9bn/aPS189xn/an/a

A214390

Kyongbo Pharmaceutical
₩7,440.000%2.9%₩177.9bn/aPE33.2xn/an/a

A067080

DAE HWA Pharmaceutical
₩9,860.00-4.8%21.0%₩177.3bn/an/an/a1.5%

A000520

Samil PharmaceuticalLtd
₩8,400.00-1.3%5.3%₩174.3bn/aPB1.1xn/a0%

A182400

NKMAX
₩2,020.000%-69.5%₩172.7bn/aPE11xn/an/a

A106190

High Tech Pharm
₩16,030.0014.5%77.3%₩170.4bn/aPE14.7xn/a0.6%

A183490

Enzychem Lifesciences
₩1,985.001.6%8.3%₩168.9bn/aPS2xn/an/a

A084990

Helixmith
₩3,570.00-6.3%-45.8%₩168.5bn/aPS46.3xn/an/a

A011000

GeneOne Life Science
₩2,055.00-7.4%-47.2%₩167.6bn/aPS4.1xn/an/a

A023910

Daihan PharmaceuticalLtd
₩28,100.00-0.2%2.2%₩165.2b₩40,500.00PE5.6xE7.0%2.7%

A084650

LabGenomics
₩2,190.00-1.4%-38.1%₩162.6b₩5,000.00PS2.1xS34.6%0%

A217730

Kangstem Biotech
₩2,895.00-13.6%-13.3%₩162.3bn/aPS13.3xn/an/a

A226950

OliX Pharmaceuticals
₩9,190.00-30.7%-44.3%₩154.0bn/aPS9.8xn/an/a

A042520

HansBiomed
₩11,800.00-3.8%-37.8%₩153.2bn/aPS2xn/a0%

A338840

Y-Biologics
₩10,160.00-0.6%n/a₩150.1bn/an/an/an/a

A002620

Jeil Pharma Holdings
₩9,800.00-1.8%-23.3%₩150.4bn/aPB0.5xn/a0.5%

A461030

IMB Dx
₩10,570.00-5.7%n/a₩148.2bn/an/an/an/a

A001360

SAMSUNG PHARM
₩1,559.002.9%-50.7%₩148.0bn/an/an/an/a
Page 5 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.